Moderna booster candidate shows strong response against Omicron subvariants
Wednesday, June 22, 2022 04:51 PM
Moderna Inc (MRNA.O) said on Wednesday that an updated version of its COVID-19 vaccine designed to target the Omicron variant also generated a strong immune response against the fast-spreading Omicron subvariants BA.4 and BA.5, which have gained a foothold in the U.S. in recent weeks. Read more.